Skip to content

Fitness Training Using WBEMS Among Individuals With SCI

Physical Fitness Training Using Whole-Body Electrical Muscle Stimulation Among Individuals Living With Chronic Spinal Cord Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04307017
Enrollment
1
Registered
2020-03-13
Start date
2020-02-01
Completion date
2020-12-31
Last updated
2021-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Physical Fitness, Whole body electrical muscle stimulation

Brief summary

Up to 15 individuals living with chronic SCI will be recruited for this study. Each participant will complete an initial clinical assessment before starting a 10-week training program. The training program will consist of three 45-minute Whole-Body Electrical Muscle Stimulation (WBEMS)-augmented exercise training sessions for 10 weeks. At each training session, all adverse events (pain, redness, injury, etc.) will be recorded along with participants' comments concerning comfort (i.e. Objective 1). The investigators hypothesize that the use of a WBEMS will result in no serious adverse effect during and following the training sessions and that it will take less than 10 minutes to don and doff the suit. At the fifth session, after participants have had the opportunity to become familiar with the WBEMS intervention, the immediate effects of the intervention on physiological responses will be assessed (i.e. Objective 2). It is hypothesized that during a single training session consisting of WBEMS and exercise, physiological responses and energy expenditure (EE) will be significantly improved in participants with SCI compared to a training session consisting solely of exercises without WBEMS. At the end of the training program, participants will complete the final clinical assessment to evaluate the therapeutic benefit of the WBEMS-augmented exercise intervention (i.e. Objective 3). Three months after the end of the training program, the participants will be asked to complete a semi-structured interview and questionnaire to evaluate the perceived benefits of the training program (i.e. Objective 3).It is also hypothesized that participants will perceive benefits of the 10-week training program such as decreased spasticity, increased energy and improved mood.

Interventions

OTHERStimaWell®EMS

The StimaWell®EMS device is a 12-channel medium-frequency device with modulated low frequency using a high-tech stimulation suit for the trunk and strap electrodes for the arms and legs allowing whole-body stimulation. The device has 70 preprogramed training programs based on goals (e.g., strengthening, endurance training, aerobic training).

Sponsors

Université de Montréal
CollaboratorOTHER
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. have a motor complete SCI (i.e., American Spinal Injury Association Impairment Scale grade A or B which means complete motor paralysis below the level of injury) at the neurological level T7 or below (i.e., to avoid triggering autonomic dysreflexia). The participants will have complete motor function of their arms but not of their legs; 2. be at least one year post-injury (i.e., chronic injury); 3. be between 18 and 65 years of age; 4. be cleared for physical activity based on The Physical Activity Readiness Questionnaire for Everyone (PAR-Q+)34 5. be able to provide informed, written consent.

Exclusion criteria

1\) Contraindications for EMS35,36. Electrical stimulation should not be applied: * if implanted electronic devices, including cardiac pacemakers * if coronary stents are present * if cosmetics and other implants are present in the application region * to pregnant women * on the regions of known or suspected malignancy * if active deep vein thrombosis or thrombophlebitis * to actively bleeding tissue or to persons with untreated hemorrhagic disorders * to infected tissues, tuberculosis, or wounds with underlying osteomyelitis * if inflammation is present in the region of application * to recently radiated tissues * to the chest in persons with cardiac disease, arrhythmias, or heart failure * to the neck or head region of persons known to have seizures * transcranially without specialized training * to areas near reproductive organs or genitalia without specialized training * to areas near or over eyes * to anterior neck or carotid sinus * to damaged or at-risk skin areas that would result in uneven conduction of current (excluding open wounds where the specific intent is to use electrical stimulation for tissue healing)

Design outcomes

Primary

MeasureTime frameDescription
Duration of Training SessionFor the 30 training sessions spread over 10 weeksTime in minutes
Intensity of Training SessionFor the 30 training sessions spread over 10 weeksType of activity; repetitions; weight resistance
Adverse EventsFor the 30 training sessions spread over 10 weeks, if necessaryAll adverse events, even minor, will be reported in the intervention CRF, and compiled in a specific document (Adverse Event Report Form) all along the study to be analyzed as an outcome of the study

Secondary

MeasureTime frameDescription
Anthropometric dataUp to 10 weeksCircumference of the waist, abdominal region, thighs, legs, arms and forearms
WeightUp to 10 weeks
Exercise Self-Efficacy QuestionnaireUp to 10 weeksUsed to assess the perception and confidence to do leisure time physical activity
Maximal Isometric Voluntary StrengthUp to 10 weeksMaximal strength of the major muscle groups of upper extremity (i.e., flexors, extensors and abductors of the shoulder, and flexors and extensors of the elbow) will be measured using hand-held dynamometer
HeightUp to 10 weeks
Body Mass IndexUp to 10 weeks

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026